Literature DB >> 11803047

Antibodies against different epitopes of heat-shock protein 60 in children with type 1 diabetes mellitus.

L Horváth1, L Cervenak, M Oroszlán, Z Prohászka, K Uray, F Hudecz, E Baranyi, L Madácsy, M Singh, L Romics, G Füst, P Pánczél.   

Abstract

The aim of this study was to investigate the amounts and epitope specificity of antibodies against heat shock protein 60 (hsp60) in the sera of type 1 diabetic and healthy children. Antibodies specific for peptide p277 of human hsp60 and of M. bovis as well as for human hsp60, M. bovis hsp65 proteins were measured by ELISA. Other autoantibodies (islet cell antibodies, glutamate decarboxylase antibodies and IA-2 antibodies) were also determined. A total number of 83 serum samples from children with type 1 diabetes mellitus and 81 samples of control children were investigated. Epitope scanning of the hsp60 for linear antibody epitopes was carried out using synthetic peptides attached to pins. The antibody levels specific for peptide p277 of human- and of M. bovis origin were significantly (human: P=0.0002, M. bovis: P=0.0044) higher in the diabetic children group than in the healthy children. We could not find significant difference in the antibody levels to whole, recombinant hsp proteins among the examined groups of children. Antibodies to two epitope regions on hsp60 (AA394-413 and AA435-454) were detected in high titres in sera of children with diabetes mellitus. The first region similar to the sequence found in glutamate decarboxylase, whereas the second one overlaps with p277 epitope to a large extent. Presence of antibodies to certain epitopes of hsp60 (AA394-413-glutamic acid decarboxylase-like epitope; AA435-454-p277-like epitope) in diabetic children may reflect their possible role in the autoimmune diabetogenic process of the early diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11803047     DOI: 10.1016/s0165-2478(01)00336-4

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  13 in total

Review 1.  Antibodies against heat shock proteins in environmental stresses and diseases: friend or foe?

Authors:  Tangchun Wu; Robert M Tanguay
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

Review 2.  Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes.

Authors:  Frank Waldron-Lynch; Kevan C Herold
Journal:  Nat Rev Drug Discov       Date:  2011-06       Impact factor: 84.694

3.  Comparison of epitope specificity of anti-heat shock protein 60/65 IgG type antibodies in the sera of healthy subjects, patients with coronary heart disease and inflammatory bowel disease.

Authors:  George Füst; Katalin Uray; László Bene; Ferenc Hudecz; István Karádi; Zoltán Prohászka
Journal:  Cell Stress Chaperones       Date:  2011-10-29       Impact factor: 3.667

4.  Circulating anti-heat-shock-protein antibodies in normal pregnancy and preeclampsia.

Authors:  Attila Molvarec; Zoltán Derzsy; Judit Kocsis; Tamás Boze; Bálint Nagy; Krisztián Balogh; Veronika Makó; László Cervenak; Miklós Mézes; István Karádi; Zoltán Prohászka; János Rigó
Journal:  Cell Stress Chaperones       Date:  2009-02-11       Impact factor: 3.667

5.  Increased levels of anti-heat-shock protein 60 (anti-Hsp60) indicate endothelial dysfunction, atherosclerosis and cardiovascular diseases in patients with mixed connective tissue disease.

Authors:  Edit Bodolay; Zoltan Prohászka; Gyorgy Paragh; Istvan Csipő; Gabor Nagy; Renata Laczik; Nora Demeter; Eva Zöld; Britt Nakken; Gyula Szegedi; Peter Szodoray
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

6.  Epitopes of microbial and human heat shock protein 60 and their recognition in myalgic encephalomyelitis.

Authors:  Amal Elfaitouri; Björn Herrmann; Agnes Bölin-Wiener; Yilin Wang; Carl-Gerhard Gottfries; Olof Zachrisson; Rϋdiger Pipkorn; Lars Rönnblom; Jonas Blomberg
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

Review 7.  Heat shock proteins (HSPs) in the homeostasis of regulatory T cells (Tregs).

Authors:  Tomasz Koliński; Natalia Marek-Trzonkowska; Piotr Trzonkowski; Janusz Siebert
Journal:  Cent Eur J Immunol       Date:  2016-10-25       Impact factor: 2.085

Review 8.  Altered immune regulation in type 1 diabetes.

Authors:  András Zóka; Györgyi Műzes; Anikó Somogyi; Tímea Varga; Barbara Szémán; Zahra Al-Aissa; Orsolya Hadarits; Gábor Firneisz
Journal:  Clin Dev Immunol       Date:  2013-08-21

9.  BCG and BCG/DNAhsp65 vaccinations promote protective effects without deleterious consequences for experimental autoimmune encephalomyelitis.

Authors:  Sofia Fernanda Gonçalves Zorzella-Pezavento; Clara Pires Fujiara Guerino; Fernanda Chiuso-Minicucci; Thais Graziela Donegá França; Larissa Lumi Watanabe Ishikawa; Ana Paula Masson; Célio Lopes Silva; Alexandrina Sartori
Journal:  Clin Dev Immunol       Date:  2013-10-29

10.  A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases.

Authors:  Julia Y Wang; Michael W Roehrl; Victor B Roehrl; Michael H Roehrl
Journal:  bioRxiv       Date:  2021-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.